Quadramet (Jazz Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Quadramet drug offered from Jazz Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Jazz Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Samarium SM 153 Lexidronam |
| SUBSTANCE NAME: | SAMARIUM SM-153 LEXIDRONAM PENTASODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-05-19 |
| END MARKETING DATE: | 0000-00-00 |
Quadramet HUMAN PRESCRIPTION DRUG Details:
| Item Description | Quadramet from Jazz Pharmaceuticals, Inc. |
| LABELER NAME: | Jazz Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mCi/mL) |
| START MARKETING DATE: | 1997-05-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57902-860_8c2bb4be-91a7-4f05-a59e-0d05f7d18332 |
| PRODUCT NDC: | 57902-860 |
| APPLICATION NUMBER: | NDA020570 |
Other SAMARIUM SM-153 LEXIDRONAM PENTASODIUM Pharmaceutical Manufacturers / Labelers:
